TG Therapeutics | TGTX - Ricavi Di Vendita





I Saldi Cambiamento Data
AbbVie USD 17.4B 410M 2026-09
Alaunos Therapeutics USD 2K 2K 2025-03
Amgen USD 10.4B 300M 2026-09
Ardelyx USD 120.88M 26.41M 2026-06
Arrowhead Research USD 75.23M 1.49M 2026-06
Bayer EUR 10.05B 820M 2026-09
Biogen USD 2.8B 60M 2026-09
Corcept Therapeutics USD 340.5M 84.35M 2026-09
Curis USD 1.14M 1.41M 2025-12
Gilead Sciences USD 8.3B 500M 2026-09
J&J USD 25.4B 89M 2026-09
Karyopharm Therapeutics USD 35.07M 987K 2026-03
Novartis USD 14.52B 112M 2026-09
Novavax USD 147.14M 76.69M 2025-12
PTC Therapeutics USD 357.8M 3.2M 2026-09
Puma Biotechnology USD 80.54M 33.46M 2024-09
Regeneron Pharmaceuticals USD 5.12B 830M 2026-09
Roche Holding CHF 30.36B 14.71B 2026-06
TG Therapeutics USD 259.94M 19.6M 2026-09
Verastem USD 18.67M 1.14M 2026-03
Vertex Pharmaceuticals USD 3.44B 110M 2026-09